Table 3.
All children | Preschool children () | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Indicator | RR | 95% CI | (%) | RR | 95% CI | (%) | RR | 95% CI | (%) | ||||||
All leukemia | 3 | 1.05 | 0.94, 1.16 | 0.0 | 0.000 | 3 | 1.04 | 0.94, 1.16 | 0.0 | 0.000 | — | ||||
Subtype | |||||||||||||||
ALL | 2 | 1.11 | 0.95, 1.31 | 0.0 | 0.000 | 2 | 1.11 | 0.95, 1.31 | 0.0 | 0.000 | — | ||||
AML | 2 | 1.00 | 0.87, 1.13 | 0.0 | 0.000 | 2 | 1.00 | 0.87, 1.13 | 0.0 | 0.000 | — | ||||
Exposure timing | |||||||||||||||
At birth | 3 | 1.05 | 0.94, 1.16 | 0.0 | 0.000 | 3 | 1.04 | 0.94, 1.16 | 0.0 | 0.000 | — | ||||
At diagnosis | — | — | — | ||||||||||||
Region | |||||||||||||||
Europe | 1 | 1.00 | 0.72, 1.39 | — | 0.000 | 1 | 0.94 | 0.62, 1.43 | — | 0.000 | — | ||||
North America | 2 | 1.05 | 0.94, 1.17 | 0.0 | 0.000 | 2 | 1.05 | 0.94, 1.17 | 0.0 | 0.000 | — | ||||
All leukemia | 2 | 1.20 | 0.70, 2.04 | 43.5 | 0.075 | 2 | 1.09 | 0.66, 1.80 | 12.3 | 0.028 | 1 | 1.50 | 0.48, 4.70 | — | 0.000 |
Subtype | |||||||||||||||
ALL | 1 | 1.45 | 0.73, 2.87 | — | 0.000 | 1 | 1.50 | 0.52, 4.33 | — | 0.000 | 1 | 1.39 | 0.54, 3.57 | — | 0.000 |
AML | 1 | 1.30 | 0.41, 4.14 | — | 0.000 | 1 | 1.21 | 0.18, 8.16 | — | 0.000 | 1 | 1.18 | 0.25, 5.56 | — | 0.000 |
Exposure timing | |||||||||||||||
At birth | 1 | 1.00 | 0.70, 1.42 | — | 0.000 | 1 | 0.97 | 0.62, 1.51 | — | 0.000 | — | ||||
At diagnosis | 1 | 1.80 | 0.82, 3.97 | — | 0.000 | 1 | 1.90 | 0.60, 6.01 | — | 0.000 | 1 | 1.50 | 0.48, 4.70 | — | 0.000 |
Region | |||||||||||||||
Europe | 2 | 1.20 | 0.70, 2.04 | 43.5 | 0.075 | 2 | 1.09 | 0.66, 1.80 | 12.3 | 0.028 | 1 | 1.50 | 0.48, 4.70 | — | 0.000 |
North America | — | — | — | ||||||||||||
1,3—Butadiene | |||||||||||||||
All leukemia | 2 | 1.45 | 1.08, 1.95 | 28.0 | 0.025 | 2 | 1.45 | 1.08, 1.95 | 28.0 | 0.025 | — | ||||
Subtype | |||||||||||||||
ALL | 2 | 1.31 | 1.11, 1.54 | 0.0 | 0.000 | 2 | 1.31 | 1.11, 1.54 | 0.0 | 0.000 | — | ||||
AML | 1 | 2.35 | 1.02, 5.40 | — | 0.000 | 1 | 2.35 | 1.02, 5.40 | — | 0.000 | — | ||||
Exposure timing | |||||||||||||||
At birth | 2 | 1.45 | 1.08, 1.95 | 28.0 | 0.025 | 2 | 1.45 | 1.08, 1.95 | 28.0 | 0.025 | |||||
At diagnosis | — | — | |||||||||||||
Region | |||||||||||||||
Europe | — | — | — | ||||||||||||
North America | 2 | 1.45 | 1.08, 1.95 | 28.0 | 0.025 | 2 | 1.45 | 1.08, 1.95 | 28.0 | 0.025 | — |
Note: —, data not available; ALL, acute lymphoblastic leukemia; AML, acute myeloid leukemia; CI, confidence interval; , I-squared statistic; RR, risk ratio; , tau-squared statistic.